| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-05 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-05 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.092 | 0.002 |